Pre-surgery proton radiation for soft tissue sarcoma
Part of Cancer clinical trials.
This trial studies a shorter-course proton radiation plan given before surgery for certain soft tissue sarcomas. The goal is to treat the tumor locally while helping surgery be safer or more effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a soft tissue sarcoma in an arm or leg, or in the trunk/torso area (not in the retroperitoneum).
- You can be classified as ECOG 0–2, meaning you’re able to do most daily activities (with limited symptoms for ECOG 1–2).
- You have not had radiation to the same local area before.
- Your treatment plan cannot include chemotherapy, targeted therapy, or immunotherapy during this trial period.
- You must be able to hold still in the required treatment and simulation position for the full appointment time.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a shorter course of radiation (just 5 days) before surgery for soft tissue sarcoma. The goal is to see if a brief, high-dose radiation schedule works as well as or better than the usual longer course—and may be more convenient for you.
This study tests a 5-day course of radiation before surgery instead of the usual 5 weeks. It may help people who face challenges like travel or tumor growth that make the longer schedule difficult.
This trial tests giving a shorter, lower-dose radiation treatment before surgery for a retroperitoneal (deep belly/back space) soft-tissue sarcoma. The goal is to shrink or control the tumor and make surgery more effective and safe.
This trial tests a shorter, more convenient radiation schedule (hypofractionated) for older or fragile adults with soft tissue sarcoma in a limb or trunk. It aims to see if this approach is safe and effective before surgery.
This trial tests if a powerful type of radiation called carbon ion therapy, given before surgery, is safe and effective for treating soft tissue sarcoma. It may help shrink the tumor before it’s removed.
This trial studies giving radiation before surgery to help control a soft-tissue sarcoma while keeping surgery as less extensive as possible. It may help shrink the tumor and improve what the surgeon can remove.
Hear when a new Soft Tissue Sarcoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.